Trial Profile
A Placebo-Controlled Study of the Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Pleconaril (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 22 Jun 2007 Status changed from in progress to completed.
- 13 Nov 2006 New trial record.